FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.464.1003.1062

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113883.3.464.1003.1062
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.1062/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1062
Version20240123
Statusactive
Date2024-01-23T01:10:32-05:00
NamePotentiallyHarmfulSkeletalMuscleRelaxantsForOlderAdults
TitlePotentially Harmful Skeletal Muscle Relaxants for Older Adults
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this value set is to represent concepts for potentially harmful Skeletal Muscle Relaxants for older adults as described in the 2023 American Geriatrics Society BEERS criteria.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable medications. Includes Carisoprodol, Metaxalone, Chlorzoxazone , Cyclobenzaprine Hydrochloride, Methocarbamol and Orphenadrine.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
rxnormRxNorm
ValueSet
2.16.840.1.113883.3.464.1003.1256Potentially Harmful Skeletal Muscle Relaxants for Older Adults

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.1062",
  "meta": {
    "versionId": "12",
    "lastUpdated": "2024-01-24T09:36:54.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "NCQA PHEMUR Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-03-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2024-01-23"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1062",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.1062"
    }
  ],
  "version": "20240123",
  "name": "PotentiallyHarmfulSkeletalMuscleRelaxantsForOlderAdults",
  "title": "Potentially Harmful Skeletal Muscle Relaxants for Older Adults",
  "status": "active",
  "date": "2024-01-23T01:10:32-05:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for potentially harmful Skeletal Muscle Relaxants for older adults as described in the 2023 American Geriatrics Society BEERS criteria.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable medications. Includes Carisoprodol, Metaxalone, Chlorzoxazone , Cyclobenzaprine Hydrochloride, Methocarbamol and Orphenadrine.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients.)",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1256"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:9335bcb0-d9bd-4fa9-a5b7-ad253cadd966",
    "timestamp": "2025-05-23T22:14:11-04:00",
    "total": 23,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1088934",
        "display": "chlorzoxazone 375 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1088936",
        "display": "chlorzoxazone 750 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197446",
        "display": "carisoprodol 350 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197447",
        "display": "aspirin 325 MG / carisoprodol 200 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197501",
        "display": "chlorzoxazone 250 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197502",
        "display": "chlorzoxazone 500 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197935",
        "display": "metaxalone 400 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197943",
        "display": "methocarbamol 500 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197944",
        "display": "methocarbamol 750 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197945",
        "display": "aspirin 325 MG / methocarbamol 400 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2611794",
        "display": "methocarbamol 1000 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2627781",
        "display": "metaxalone 640 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "351254",
        "display": "metaxalone 800 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "730794",
        "display": "carisoprodol 250 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "828299",
        "display": "cyclobenzaprine hydrochloride 7.5 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "828320",
        "display": "cyclobenzaprine hydrochloride 5 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "828348",
        "display": "cyclobenzaprine hydrochloride 10 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "828353",
        "display": "24 HR cyclobenzaprine hydrochloride 30 MG Extended Release Oral Capsule"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "828358",
        "display": "24 HR cyclobenzaprine hydrochloride 15 MG Extended Release Oral Capsule"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "994226",
        "display": "aspirin 325 MG / carisoprodol 200 MG / codeine phosphate 16 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "994521",
        "display": "12 HR orphenadrine citrate 100 MG Extended Release Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "994528",
        "display": "aspirin 385 MG / caffeine 30 MG / orphenadrine citrate 25 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "994535",
        "display": "aspirin 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet"
      }
    ]
  }
}